Art

J-GLOBAL ID：201902216557103397   Reference number：19A2576714

Evaluation of 8-week glecaprevir/pibrentasvir treatment in direct-acting antiviral-naieve noncirrhotic HCV genotype 1 and 2infected patients in a real-world setting in Japan

日本における実世界環境での直接作用性抗ウイルス性非ナイーブHCV遺伝子型1および2感染患者における8週間のグレカプレビル/ピブレタビル治療の評価【JST・京大機械翻訳】

Author (39)： Ikeda Hiroki (Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan) ,  Watanabe Tsunamasa (Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan) ,  Atsukawa Masanori (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan) ,  Toyoda Hidenori (Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan) ,  Takaguchi Koichi (Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan) ,  Nakamuta Makoto (National Hospital Organization Kyushu Medical Center, Fukuoka, Japan) ,  Matsumoto Nobuyuki (Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan) ,  Okuse Chiaki (Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan) ,  Tada Toshifumi (Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan) ,  Tsutsui Akemi (Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan) ,  Yamashita Naoki (National Hospital Organization Kyushu Medical Center, Fukuoka, Japan) ,  Kondo Chisa (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan) ,  Hayama Korenobu (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan) ,  Kato Keizo (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Shinmatusdo Central General Hospital, Matsudo, Japan) ,  Itokawa Norio (Department of Internal Medicine, Division of Gastroenterology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan) ,  Arai Taeang (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan) ,  Shimada Noritomo (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Japan) ,  Asano Toru (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan) ,  Uojima Haruki (Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Kanagawa, Japan) ,  Ogawa Chikara (Department of Gastroenterology and Hepatology, Takamatsu Red Cross Hospital, Takamatsu, Japan) ,  Mikami Shigeru (Department of Internal Medicine, Division of Gastroenterology, Kikkoman General Hospital, Noda, Japan) ,  Ikegami Tadashi (Ibaraki Medical Center, Tokyo Medical University, Ibaraki, Japan) ,  Fukunishi Shinya (Second Department of Internal Medicine, Osaka Medical College, Osaka, Japan) ,  Asai Akira (Second Department of Internal Medicine, Osaka Medical College, Osaka, Japan) ,  Iio Etsuko (Department of Virology & Liver Unit, Graduate School of Medical Sciences, Nagoya City University, Aichi, Japan) ,  Tsubota Akihito (Core Research Facilities for Basic Science, The Jikei University School of Medicine, Tokyo, Japan) ,  Hiraoka Atsushi (Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan) ,  Nozaki Akito (Gastroenterological Center, Yokohama City University Medical Center, Kanagawa, Japan) ,  Okubo Hironao (Department of Gastroenterology, Juntendo Nerima University Hospital, Tokyo, Japan) ,  Tachi Yoshihiko (Bantane Hospital, Fujita Health University School of Medicine, Nagoya, Japan) ,  Moriya Akio (Department of Gastroenterology, Mitoyo General Hospital, Kannonji, Japan) ,  Oikawa Tsunekazu (Department of Gastroenterology and Hepatology, The Jikei University School of Medicine, Tokyo, Japan) ,  Matsumoto Yoshihiro (Department of Gastroenterology and Hepatology, The Jikei University School of Medicine, Kashiwa Hospital, Kashiwa, Japan) ,  Tsuruoka Shuichi (Department of Internal Medicine, Division of Nephrology, Nippon Medical School, Tokyo, Japan) ,  Tani Joji (Department of Internal Medicine, Yashima General Hospital, Takamatsu, Japan) ,  Kikuchi Kan (Shimo-Ochiai Clinic, Tokyo, Japan) ,  Iwakiri Katsuhiko (Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan) ,  Tanaka Yasuhito (Department of Virology & Liver Unit, Graduate School of Medical Sciences, Nagoya City University, Aichi, Japan) ,  Kumada Takashi (Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan)
Material： Journal of Viral Hepatitis
Volume： 26  Issue： 11  Page： 1266-1275  Publication year： 2019 
JST Material Number： W2670A  ISSN： 1352-0504  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： Based on high efficacy and saf...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A2576714&from=J-GLOBAL&jstjournalNo=W2670A") }}

Thesaurus term： *antiviral action ,  man ,  clinical trial ,  population(statistics) ,  *therapy ,  safety ,  effectiveness ,  hepatitis C virus ,  liver cirrhosis ,  *genotype
Semi thesaurus term： 有害事象 ,  アミノ酸置換 ,  ウイルス学 ,  サブタイプ , 【Automatic Indexing@JST】

Author keywords (5)： glecaprevir ,  hepatitis C virus ,  pibrentasvir ,  real world ,  sustained virologic response

JST classification (5)： Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G) ,  Clinical application of antiviral drugs  (GW17050Z) ,  Infectious diseases,parasitics diseases in general.  (GD01010H) ,  Treatment for infectious diseases,parasitic diseases.  (GD01030D) ,  Tumors(=neoplasms)of digestive system  (GH04000D)

Substance index (1)： Glecaprevir

Terms in the title (10)： 日本 ,  世界 ,  環境 ,  抗ウイルス性 ,  HCV遺伝子型 ,  感染 ,  患者 ,  グレカプレビル ,  治療 ,  評価